Ken Takahashi

Honorary International Advisor (ADRI, Australia) | Adjunct Professor (UWA, Australia) | Emeritus Professor (UOEH, Japan) | Occup Physician (JEOL Ltd, Japan)

[Ken Takahashi @KenTaka_ADRI]

Proud to have worked with my international colleagues for this publication.

[Anna Nowak @perth_meso_dr]

Most likely my last publication for 2022...with @KenTaka_ADRI ...still working to understand, highlight and remove the scourge of #asbestos from our world.
https://t.co/5blaPKDFQy
@NCARD_research @UWAresearch @ADRI_Research @ADSA_WA @SPGH_UWA @ReflectAsbestos @imig2023

[Ken Takahashi @KenTaka_ADRI]

@perth_meso_dr @ADRI_Research @NCARD_research Thank you Anna for the kind words, always. ADRI looks very much forward to strengthening the collaboration with NCARD.

[Ken Takahashi @KenTaka_ADRI]

ADRI delivered workshop on ARD (mesothelioma) diagnosis in Fiji with @WHOWPRO and @FNU https://t.co/lWXCvY7YXP

[Ken Takahashi @KenTaka_ADRI]

Snapshot from ADRI-WHO workshop on diagnosis of mesothelioma in Fiji @WHOWPRO

[Ken Takahashi @KenTaka_ADRI]

When rich nations banned deadly asbestos, the industry fought to keep it... https://t.co/6arkcHmEDJ via @YouTube

[Ken Takahashi @KenTaka_ADRI]

Asbestos - A Call for Advancing Awareness and Science https://t.co/SjskYCLKeO

[Ken Takahashi @KenTaka_ADRI]

Collaborative research article between China Medical University and ADRI in Lancet Planetary Health | "Implementation of national policies for a total asbestos ban: a global comparison" #asbestos #asbestosban https://t.co/rswHrKt82z

[Ken Takahashi @KenTaka_ADRI]

Rare article on national situation of #Mesothelioma in #China by Zhao J et al in Chin J Cancer Res 2017; https://t.co/IX4RVPyY53

[Ken Takahashi @KenTaka_ADRI]

Meet our researchers and read about ADRI's novel research work on #ARDs and #mesothelioma in our Annual Report. https://t.co/nB41LRJLgC

[Ken Takahashi @KenTaka_ADRI]

https://t.co/OcZUvteuxj https://t.co/4P5TSbopVx

[Ken Takahashi @KenTaka_ADRI]

Independent risk assessment necessary for new technology to treat asbestos mining residue
https://t.co/ChLurqw2aH https://t.co/y9tmfLE8Zw

[Ken Takahashi @KenTaka_ADRI]

To summarise, 1. Immunotherapy; 2. Liquid biopsy tests; 3. Side effects of cancer treatment & survival; 4. Cancer and MICROBIOME; 5. Organoids https://t.co/GSampT7ED4

[Ken Takahashi @KenTaka_ADRI]

Five Things To Look Out For In Cancer Research In 2019 - Forbes
1 Immunotherapy 2 Liquid biopsy tests 3 Side-effects of cancer treatment and survival 4 cancer and Microbiome 5 Organoids

[Ken Takahashi @KenTaka_ADRI]

https://t.co/fJVoMKWYZF #cancer #molecularbiology #mesothelioma https://t.co/GgX8EzeLfe

[Ken Takahashi @KenTaka_ADRI]

ADRI Newsletter “Fibres” Just Out (Dec 2018 Issue)

#fibre #newsletters https://t.co/RFa6ftKfi2

[Ken Takahashi @KenTaka_ADRI]

https://t.co/WpYrEmcBlI https://t.co/AV6Ct2GD33

[Ken Takahashi @KenTaka_ADRI]

@SlaterGordon On behalf of ADRI, thank you so much!